Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG). - Hauschild,A.; Garbe,C.; Stolz,W.; Ellwanger,U.; Seiter,S.; Dummer,R.; Ugurel,S.; Sebastian,G.; Nashan,D.; Linse,R.; Achtelik,W.; Mohr,P.; et al. (Br J Cancer, 2001)